Mauritania approves decree for local drug manufacturing
A new government decree aims to regulate pharmaceutical factories, boost domestic supply, and reduce reliance on imported medicines.
Mauritania's Council of Ministers has approved a draft decree to establish procedures for opening pharmaceutical manufacturing facilities. The decree outlines technical standards and operational conditions for these establishments, addressing a regulatory gap in local drug production.
The new regulation seeks to develop a domestic pharmaceutical industry capable of ensuring a stable supply of medicines. By reducing dependence on imports, the government aims to enhance Mauritania's health sovereignty. The decree also details application processes for manufacturing licenses and establishes a commission to review applications.
Furthermore, the legislation lays the groundwork for good manufacturing practices for human-use drugs. It also introduces a system to coordinate local production with medicine imports, aiming for a more integrated national health supply chain.
Why it mattersThe decree affects Mauritanians by aiming to ensure a more stable and potentially affordable supply of medicines through local production.